CEO and Co-Founder

Chase earned his Ph.D. at the University of Kentucky working with Dr. Joe Chappell, advancing triterpene production platforms. Chase was part of a team that implemented CLIA Certified, SARS-COV-2 testing for over 4,000 patients per day in the greater Bluegrass region prior to turning his full attention to leading the Enepret and EVAX efforts.

Scientific Advisor and Co-Founder

Joe is a senior faculty member in the Department of Pharmaceutical Sciences at the University of Kentucky College of Pharmacy. With many decades of experience in terpene chemistry and biochemistry, Joe has equally strived to see these technologies deployed for improved health care therapeutics.

COO

Mizuki earned her Ph.D. at the University of Kentucky prior to joining the Chappell lab overseeing their preclinical trials with oil-in-water adjuvants. Mizuki manages the quality control and quality assurance programs within Enepret and EVAX.